Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:37:46.483Z.
Calculation as of: 2026-10-06T20:37:46.483Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 23d17170dcd90d56222e16e6e1c46ca5d6e49f0f5e08d353dc7d5f06f7b1586d
EARNINGS YIELD
N/A
Market Cap
$9.63B
Earnings Yield
2.44%
TTM Avg
2.52%
3Y Avg
2.01%
5Y Avg
2.01%
Market Cap
$9.87B
Earnings Yield
0.42%
TTM Avg
0.38%
3Y Avg
0.46%
5Y Avg
0.92%
Market Cap
$9.93B
Earnings Yield
2.24%
TTM Avg
4.64%
3Y Avg
4.54%
5Y Avg
13.42%
Market Cap
$10.03B
Earnings Yield
3.71%
TTM Avg
3.29%
3Y Avg
3.33%
5Y Avg
3.72%
Market Cap
$10.13B
Earnings Yield
4.07%
TTM Avg
3.46%
3Y Avg
2.91%
5Y Avg
2.63%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.63B | N/A | N/A | N/A | N/A |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | 2.44% | 2.52% | 2.01% | 2.01% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 4.04% | 4.20% | 4.23% | 4.69% |
| Repligen Corporation (RGEN)vs › | $9.87B | 0.42% | 0.38% | 0.46% | 0.92% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 2.24% | 4.64% | 4.54% | 13.42% |
| Insulet Corp. (PODD)vs › | $9.33B | 3.97% | 2.11% | 1.85% | 1.26% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 3.71% | 3.29% | 3.33% | 3.72% |
| Bruker Corporation (BRKR)vs › | $9.21B | N/A | 2.22% | 2.91% | 2.67% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 4.07% | 3.46% | 2.91% | 2.63% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
